» Articles » PMID: 23990396

Recurrence of a Functional Adrenocortical Oncocytoma of Borderline Malignant Potential Showing High FDG Uptake on 18F-FDG PET/CT

Overview
Journal Ann Nucl Med
Date 2013 Aug 31
PMID 23990396
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Adrenocortical oncocytoma is a very rare tumor, which is not malignant and nonfunctioning in most cases. We report a case of a 53-year-old male with a 9.8 cm sized hyperfunctioning, well-encapsulated adrenal mass, which exhibited by high FDG uptake on a PET/CT scan. The patient had complained of symptoms of Cushing's syndrome for 4 months. Laparoscopic adrenalectomy was performed and the mass was pathologically confirmed as adrenocortical oncocytoma of uncertain malignant potential. Four years after surgery, the tumor recurred with distant metastases, which was proven by subsequent biopsy. 18F-FDG PET/CT also showed hypermetabolism in the recurred tumor and multiple metastatic lesions. Adrenocortical oncocytoma of borderline malignant potential with high FDG uptake may require long-term follow-up with clinical, hormonal, and imaging evaluations.

Citing Articles

Adrenal oncocytoma: a rare presentation of a benign 18 F-fluorodeoxyglucose PET avid virilising adrenal tumour.

Lee D, Green J, Crane J, Taylor D, Reynolds S, Ng W Nucl Med Commun. 2024; 46(4):367-372.

PMID: 39604271 PMC: 11878579. DOI: 10.1097/MNM.0000000000001932.


Prognosis of Adrenal Oncocytic Neoplasms (AONs): Literature Review of 287 Cases and Presentation of the Oldest Patient.

Coppola Bottazzi E, Gambardella C, Mongardini F, Vanella S, Noviello A, Palma T J Clin Med. 2023; 12(21).

PMID: 37959390 PMC: 10649738. DOI: 10.3390/jcm12216925.


Case Report: Adrenocortical Oncocytoma in a Patient with a Previous Contralateral Adrenalectomy for a Cortisol-Secreting Adenoma.

Canu L, Perigli G, Badii B, Santi R, Nesi G, Pradella S Front Surg. 2022; 9:897967.

PMID: 35662823 PMC: 9160572. DOI: 10.3389/fsurg.2022.897967.


Oncocytic adrenocortical neoplasm with undetermined malignant potential and autonomous cortisol secretion.

San Juan M, Lagamayo D, Carnate J, Joven M BMJ Case Rep. 2022; 15(4).

PMID: 35444021 PMC: 9021750. DOI: 10.1136/bcr-2021-248525.


Adrenocortical neoplasm of uncertain malignant potential with a myelolipomatous component.

Balasubramanian A, Scovell J, Dowell A, Mayer W BMJ Case Rep. 2020; 13(6).

PMID: 32532913 PMC: 7295410. DOI: 10.1136/bcr-2020-234591.